Discover 1,584 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,584
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor,
Location: Denver CO, Tucson AZ, Cleveland OH, Washington D.C. DC,
Sponsor: Vaxiion Therapeutics
Sex: All
Age: 18+
Code: NCT05901285
Phase1, Recruiting
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
for
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8,
Location: Denver CO, Duarte CA, Houston TX, Nashville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06292780
Phase1, Phase2, Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
for
Multiple Myeloma
Location: Longmont CO, Greeley CO, Loveland CO, Fort Collins CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06152575
Phase3, Recruiting
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
for
Lymphoma, B-Cell, Lymphoma, T-Cell
Location: Denver CO, Sarasota FL, New York NY
Sponsor: Step Pharma, SAS
Sex: All
Age: 18+
Code: NCT05463263
Phase1, Phase2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Denver CO, Salt Lake City UT, Kansas City KS, Tucson AZ,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase3, Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Denver CO, Salt Lake City UT, Westwood KS, Gilbert AZ,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06297226
Phase2, Recruiting
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration